Electrospun soy protein scaffolds as wound dressings: Enhanced reepithelialization in a porcine model of wound healing  by Har-el, Yah-el et al.
Wound Medicine 5 (2014) 9–15Electrospun soy protein scaffolds as wound dressings: Enhanced
reepithelialization in a porcine model of wound healing
Yah-el Har-el a, Jonathan A. Gerstenhaber a, Ross Brodsky a, Richard B. Huneke b,
Peter I. Lelkes a,*
aDepartment of Bioengineering, Temple University, 1947 North 12th Street, Philadelphia, PA 19122, United States
bDepartment of Microbiology and Immunology, Drexel University College of Medicine, 245 North 15th Street, MS 436, Philadelphia, PA 19102, United States
A R T I C L E I N F O
Article history:
Received 18 April 2014
Accepted 24 April 2014
Available online 2 May 2014
Keywords:
Soy protein
Electrospinning
Scaffold
Wound healing
Porcine animal model
Reepithelialization
A B S T R A C T
In this study we describe the use of an electrospun soy protein-based tissue scaffold (SPS) as a bioactive
wound dressing in a pig model of full thickness excisional wound healing. The time course of wound
healing and the quality of the healing tissue were evaluated using histology (H&E and Masson’s
trichrome staining). While the overall rate of wound closure was similar in the SPS-treated vs. untreated
control wounds covered with Tegaderm1, there were signiﬁcant qualitative differences between the two
groups. Two weeks after a single application of SPS at the time of wounding, the SPS treated wounds
showed robust signs of reepithelialization, which was absent in the control wounds. After 4 weeks, the
SPS treated wounds contained a stratiﬁed epithelial layer in the epidermis that looked essentially
normal, while the connective tissue in the dermis was attaining a cellular, organized appearance. By
contrast the nascent epidermis of the untreated controls appeared immature, while the dermis was still
replete with numerous inﬂammatory/immune cells. Masson’s trichrome staining conﬁrmed the
increased presence of collagen in the dermis of the SPS treated wounds at 4 weeks, while the control
wounds were largely devoid of collagen. Finally, in addition to enhanced reepithelialization and dermal
tissue regeneration, 4 weeks after application of the SPS dressing, we observed the presence of dermal
appendages, such as sweat glands and hair follicles. No such appendage formation was observed in the
untreated controls during the entire duration of our study. Taken together, the histological data clearly
indicate that our soy protein based scaffolds accelerated and enhanced a more natural mode of tissue
regeneration in the porcine model of full thickness excisional wound healing. Given the similarities
between porcine and human wound healing, we anticipate that SPS will also be advantageous in clinical
applications.
 2014 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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The current gold standard for treating chronic wounds is to use
autologous skin grafts, of which there is a limited supply. Skin
substitutes are plentiful, ranging from transplantation of cadaveric
skin, allogeneic cell-based skin substitutes and acellular tissue
scaffolds. Yet each of these alternatives comes with their own
limitations. Skin substitutes containing human cells exhibit large* Corresponding author: Fellow, American Institute for Medical & Biological
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3.0/).variability when used in full thickness wounds and there is a need
to delay treatment while these cells are cultured [1]. Acellular
cadaveric and allogeneic skin substitutes have the potential of
transmitting disease and some patients will also oppose them on
religious grounds [2]. Some of the ‘‘natural’’ xenogeneic acellular
scaffolds are derived from decellularized animal tissue and carry
the risk of disease transfer and may also carry an ethno-cultural
stigma. Scaffolds made from synthetic materials have also been
widely investigated, but they do not elicit biological cues similar to
native extracellular matrix (ECM), they do not have mechanical
properties similar to that of skin, and in many cases they are not
biodegradable [3].
Acellular tissue scaffolds made from non-animal materials,
speciﬁcally of plant constituents, do not exhibit any of these
limitations. Plant derived scaffolds are being used in an increasing
number of tissue engineering applications [4]. Such ‘‘green’’
scaffolds can be manufactured from a variety of alimentary plantle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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distinct processes, including electrospinning [5–13]. Electrospin-
ning is a platform technology originally developed to create non-
woven fabrics in the textile industry. Today it is being applied in
the biomedical ﬁeld to build nanoﬁbrous three-dimensional
scaffolds to mimic the natural ECM [14].
Recently, a number of laboratories, including ours have
successfully electrospun puriﬁed soy protein isolate (SPI) under
a variety of conditions [11–16]. Our previous studies have shown
that SPI can be electrospun without any cross-linkers into a stable
tissue scaffold that has mechanical properties similar to those of
human skin [11,12]. In addition, SPI resorbs into the body and
contains bioactive, ‘‘cryptic’’ peptides [17]. For example, two of
these peptides, lunasin and Bowman–Birk inhibitor, inhibit cancer
cells cultured in vitro and suppress carcinogenesis in animal
models in vivo [18,19].
We hypothesized that wound dressings made of SPI (opera-
tionally termed Soy Protein Scaffolds, SPSs) might contribute to a
more natural healing process and be a suitable alternative or
adjuvant to currently available treatments for chronic cutaneous
wounds. Previously, we optimized conditions for consistently
electrospinning bead-free submicron-size ﬁbers from SPI with a
minimal addition of high molecular weight synthetic polymer,
poly(ethylene oxide) (PEO), to increase chain entanglement
[11,12]. In vitro, these scaffolds are cytocompatible, promoting
adhesion and proliferation of primary human dermal ﬁbroblasts
[11,12].
There are a number of animal models of wound healing for
testing these scaffolds in vivo. Amongst the advantages of rodent
models are the ease of handling/housing and the relatively low
costs [20,21]. As disadvantages, rodent skin is distinctly different
from that of humans in terms of physical properties, such as thin
epidermis and dermis and the amount of body hair, and how they
heal, which is mostly by wound contraction [22]. The pig is a larger
animal; porcine skin lesions heal similarly to man, mainly through
reepithelialization [22]. The porcine model also has other features
in common with human skin, such as a thick epidermis and a
similar dermal–epidermal thickness ratio. Moreover, there is a
similar distribution, size and orientation of blood vessels and
sparse body hair [22]. For this reason we tested the efﬁcacy of SPSs
in full thickness excisional wounds in a porcine model. Our results
indicate the SPSs enhance reepithelialization and tissue regenera-
tion including restoration of skin appendages, such as sweat glands
and hair follicles.Fig. 1. Placement of wounds onto the back of a pig model and treatment of an excisional 
back. Panel B: Application of a dry Soy Protein Scaffold (SPS) to a full thickness excisio
hydration of the scaffold.2. Materials and methods
2.1. Preparation of protein solutions
Soy protein isolate (SPI) was obtained from Cargill Health and
Food Technologies (Minneapolis, MN, USA). SPI and poly(ethylene
oxide) (PEO; Sigma, St. Louis, MO, USA) were combined by ﬁrst
dissolving 0.5% w/v PEO in 1,1,1,3,3,3-hexaﬂuoro-2-propanol
(HFP; Sigma) and adding appropriate volumes from this stock
solution to 7% SPI in HFP. Solutions were left to stir at room
temperature for at least 8 days before electrospinning to ensure
complete and homogeneous dissolution.
2.2. Electrospinning
Soy Protein Scaffolds (SPSs) (5 cm  5 cm) were electrospun
essentially as previously described [11,12,23]. Brieﬂy, a digital
precision syringe pump (KD Scientiﬁc Single Syringe Infusion
Pump, Fisher Scientiﬁc) was set up horizontally to eject the SPI/PEO
solution from a disposable syringe (BD Biosciences, Franklin Lakes,
NJ, USA) through a blunt 18-gauge needle. The electrospinning
parameters were as follows: Delivery rate – 0.8 mL/h, air gap
distance – 15 cm and accelerating voltage of 12 kV. Under the
optimized conditions we consistently produced bead-free ﬁbers
that formed scaffolds (mats) with a randomly oriented ﬁbrous
structure [12].
2.3. In vivo pig model
All animal procedures were carried out according to protocols
approved by Drexel University’s Institutional Animal Care and Use
Committee. For the results reported here 3 Yorkshire pigs (35–40
pounds) were purchased from John Meck LLC (Refton, PA). After
acclimatization in the animal facility for at least 1 week, the
animals were anesthetized with isoﬂurane gas. The surgical site
was sterilized before proceeding. Sixteen square target areas
(3 cm  3 cm) were marked with a surgical pen, with eight wounds
on each side of the spine in two rows of four wounds (see Fig. 1).
At each time point (4 weeks, 2 weeks, and 1 week prior to
euthanasia) four or ﬁve full thickness wounds were excised at the
location of the markings. SPSs were applied as dry scaffolds and
hydrated in situ with a sterile solution then trimmed to ﬁt the
wound (Fig. 1, panels A and B). Some of the wounds were left
untreated and served as controls. All wounds were securedwound with soy protein scaffold. Panel A: 16 wounds were mapped out on the pig’s
nal wound. Panel C: Appearance of the SPS treated wound immediately after full
Fig. 2. Appearance of a representative experimental ﬁeld on the back of a pig
following euthanasia. The markings outline the areas of tissue collected for
histological examination. Top row: Control-2 weeks; SPS-4 weeks; SPS-1 week;
SPS-2 weeks. Bottom row: SPS-4 weeks; SPS-2 weeks; Control-4 weeks; Control-1
week.
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derm1) to keep them moist and prevent bacterial/fungal
contamination. All wounds were then covered with a layer of
gauze, cast padding and a self-adherent wrap to prevent pigs from
removing the individual bandages by rubbing against the walls of
their pens. At the end of the study (4 weeks), the pigs were
euthanized using sodium pentobarbital and phentoyin as per
IACUC protocol.
2.4. Histology
Upon euthanasia, the wounded skin area and 2 cm of healthy
skin surrounding it were excised down to the muscle and ﬁxed in
10% buffered formalin ﬁrst for one hour at room temperature and
then for at least 24 h at 4 8C. The tissue sections were embedded in
parafﬁn and then cut into 5 mm thick sections and mounted on
glass microscope slides. The samples underwent routine histologi-
cal processing for hematoxylin and eosin (H&E) staining or were
stained with Masson’s trichrome stain (MTS), following estab-
lished procedures [24–26]. The slides were dehydrated, mounted
in Richard-Allan Cytoseal-60 mounting medium and imaged with a
Nikon Microphot-FX with a Leica DFC310 FX camera using Leica
Application Suite 4.3.0.
3. Results and discussion
The porcine model of full-thickness excision wounds is widely
accepted as one that closely mimics human dermal healing [22].
Due to the animals’ large size, up to 16 wounds (3 cm  3 cm) can
be generated on each pig, concomitantly, or, as in this study,
sequentially (see below), with each wound spaced far enough apartFig. 3. Close-up photographs of the healing process of full thickness excisional wounds. Pa
on days 5, 9, and 15, respectively. Panels D–F: Following one representative untreatedso that inﬂammation from any two wounds did not overlap (Fig. 1,
panel A).
In order to compare the time course of healing of Soy Protein
Scaffold (SPS)-treated and untreated wounds, each pig received 16
square full thickness excisional wounds (3 cm  3 cm), which were
applied in a staggered fashion on three time points, 4 weeks, 2
weeks, and 1 week prior to euthanasia. At each time point, wounds
were either treated by directly applying SPS (Fig. 1, panels B and C)
or they were left untreated (sham) as a control. In this way, we
were able to establish the time course of wound healing
independently and individually. Using this staggered approach,nels A–C: Photographs of one representative wound treated with SPS. Images taken
 control wound. Images taken on days 5, 9, and 15, respectively.
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termination of the experiments and, importantly, each animal also
served as its own control. This is signiﬁcant, as we observed that
each pig had a slightly different overall healing rate.
Shown in Fig. 2 is the overall appearance of a representative
experimental ﬁeld of eight wounds following euthanasia of the
animal. Seen in this photograph are control and SPS-treated
wounds at different stages of healing (1 week, 2 weeks, and 4
weeks). In terms of overall external appearance the kinetics of
wound closure appears to be quite similar (Fig. 2), albeit there are
some differences in terms of the quality of the wounds, as more
clearly visible in the representative close-up photographs of SPS
treated and control wound at days 5, 9 and 15 (Fig. 3).
Taken together, these photographs did not reveal a signiﬁcant
acceleration of wound closure per se, as already observed in
preliminary studies using a rat model [11]. Rather the quality of the
wounds, in terms of the reduced oozing and inﬂammation
(redness), was signiﬁcantly improved in the SPS treated samples.
The beneﬁcial effects of SPSs on the wound healing process,
especially in terms of reepithelialization and regeneration of skin
appendages became evident upon histological analysis of the
wounds (Fig. 4). Shown in Fig. 4, panels A–D are low and higher
magniﬁcations of histological sections (H&E stains) of healthy
tissues.Fig. 4. Micrographs of H&E stained tissues. Panels A–D: Control panels. Micrographs of no
of never wounded skin taken from an area far away from any wound (original magniﬁc
controls samples harvested 2 weeks after injury. Note the increased number of inﬂamma
Panels E–H: 2 weeks after injury. Panels E and F: Micrographs of the central wound are
abundance of inﬂammatory/immune cells and absence of an epithelial layer in the dis
(original magniﬁcation 63, 200, respectively). Wounds treated with SPS exhibit sig
structured and there is a well-formed stratiﬁed epithelial layer. Panels I–L. 4 weeks af
untreated controls (original magniﬁcation 63, 200, respectively). The tissue in the
rebuilding of the connective tissue, the number of inﬂammatory/immune cells is diminis
L: Wounds treated on day 0 with SPS (original magniﬁcation 63, 200, respectively). In
diminished, the connective tissue in the dermis is much better organized/structured and
with clear evidence for stratiﬁcation. Note also the abundance of small blood vessels iPanels A and B show the appearance of normal skin (taken from
an area of the pig’s back that had not been wounded), including
transverse (cross)-sections of some hair shafts. Shown in panels C
and D are micrographs of histological sections of tissue taken at the
‘‘normal’’ edges of untreated control wounds, indicating some
inﬁltration of inﬂammatory/immune cells beyond the level found
far from the wounds, as seen in panels A and B.
Two weeks after wounding, the dermis of the untreated
controls (Fig. 4, panels E and F) is composed of disorganized
granulation tissue replete with copious amounts of inﬂammatory/
immune cells. Notable is the absence of any epidermal layer, as
reepithelialization has not yet occurred. By contrast, in the SPS-
treated samples (Fig. 4, panels G and H), the dermis appears more
organized, there seem to be far fewer inﬂammatory/immune cells,
and there is clear evidence for the reestablishment of the
beginnings of a stratiﬁed epithelial layer.
Shown in Fig. 4, panels I–L, are micrographs taken 4 weeks after
injury at the center of untreated controls (panels I and J) and
wounds treated on day 0 with SPSs (panels K and L). The tissue in
the untreated controls begins to show signs of organization and
rebuilding of the connective tissue (including ﬁbroblast/smooth
muscle cells), the number of inﬂammatory/immune cells is
diminished and there is a an epithelial layer which lacks normal
stratiﬁcation (panels I and J).rmal healthy tissue at low and high magniﬁcations. Panels A and B: A control sample
ation 63, 200, respectively). Panels C and D: The ‘‘healthy margin’’ of untreated
tory cells in the ‘‘healthy margins’’ (original magniﬁcation 63, 200, respectively).
a in untreated controls (original magniﬁcation 63, 200, respectively). Note the
organized granulation tissue. Panels G and H: Wounds treated on day 0 with SPS
niﬁcantly fewer inﬂammatory/immune cells, the tissue itself is more organized/
ter injury. Panels I and J: Micrographs taken 4 weeks after injury at the center of
 untreated controls (panels I and L) begins to show signs of re-organization and
hed and there is a less stratiﬁed, but clearly discernable epithelial layer. Panels K and
 the wounds treated with SPS, the number of inﬂammatory/immune cells is greatly
 has developed dermal papillae and there is a well-formed stratiﬁed epithelial layer
n the dermis close to the epidermis.
Fig. 5. Micrographs of tissue 4 weeks after injury and stained with Masson’s trichrome stain (MTS). Original magniﬁcation 200. Panel A: ‘‘Healthy’’ skin taken not far from
untreated control. Panel B: Wound area of an untreated control. Panel C: Wound area of SPS treated wound.
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while the tissue is still not quite normal (see panels A and B) the
number of inﬂammatory/immune cells is greatly diminished,
while the connective tissue is much better organized/structured
and contains ample stromal cells (ﬁbroblast and muscle cells). The
dermis has developed dermal papillae and there is a well-formed
stratiﬁed epithelial layer with clear evidence for stratiﬁcation,
including basal layer and well developed stratum corneum. Note
also the abundance of small blood vessel in the dermis close to the
epidermis (panels K and L).
One of the hallmarks of tissue regeneration is the formation of
collagen, which is critical for the function and structure of healthy
skin. Shown in Fig. 5 are histological sections of control skin,
untreated and SPS treated wounds (4 weeks) stained with
Masson’s trichrome, in which collagen is stained in blue. As seen
in panel A, collagen is abundantly present in the dermis of normal
tissue at the margin of untreated controls. By contrast collagen is
largely missing in the untreated wounds, even after 4 weeks, the
tissue lots of inﬂammatory/immune cells (panel B). By contrast, the
SPS-treated wounds, albeit still not completely normal, show
signiﬁcant levels of collagen (panel C). Taken together the
histological data clearly indicate that our soy protein based
scaffolds accelerated and enhanced a more natural mode of tissue
regeneration in the porcine model of full thickness excisional
wound healing.Fig. 6. Formation of appendages in SPS treated wounds after four weeks. Panels A and B:
SPS-treated wounds. Original magniﬁcation 25. Panels C and D: Higher magniﬁcationsIn addition to enhanced reepithelialization, 4 weeks after
application of the SPS dressing, we observed the presence of
dermal appendages, such as sweat glands and hair follicles (Fig. 6).
No such appendage formation was observed in the untreated
controls during the entire duration of our study. The overview low
magniﬁcation H&E stained micrographs in Panels A and B show the
emergence of sweat glands in the SPS-treated wounded areas close
to the epidermis. The higher resolution micrographs in panels C
and D show a growing hair shaft and nascent sweat gland,
respectively, embedded into a fairly well organized connective
tissue environment.
We note that in this pig model, the soy scaffolds seem to exert
their beneﬁcial effects not so much in terms of accelerating wound
closure (Figs. 2 and 3) but rather in the quality of wound healing
(Figs. 4–6). Conventionally, the superiority of a new ‘‘device’’,
wound dressing, or skin substitute to enhance wound healing is
often assessed in terms of accelerating wound closure. However,
we posit that acceleration of wound closure may lead to enhanced
contraction and scar tissue formation by enhanced myoﬁbroblast
differentiation [27] and hypothesize that the functional tissue
restoration will require restoration of ‘‘normal’’ tissue morphology,
as seen with SPS treatment, rather than rapid closure/contraction.
Of particular interest in this context is the more rapid and more
natural/complete reepithelialization of the SPS-treated wounds,
including formation of the Malpighian layer (stratum basale and Representative micrographs of histological sections taken at center of two different
 of appendage formation in wounds treated with SPS. Original magniﬁcation 200.
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appendages, such as sweat glands and hair shafts/follicles.
The mechanism of action by which SPS enhances a more
natural, regenerative wound healing remains to be determined. In
preliminary studies we determined that the soy scaffolds are
susceptible to proteolytic degradation in vitro [11] and that upon
s.c. implantation the scaffolds are rapidly degraded and completely
absorbed in about 14 days (Y. Har-el and P.I. Lelkes, unpublished
data). As seen from the histological micrographs (Fig. 4), soy
protein scaffolds are rapidly degraded during the wound healing
process and fully adsorbed after 4 weeks. We therefore hypothe-
size that proteolytic degradation of SPSs might liberate some of the
cryptic peptides contained in the soy proteins and that some of
these peptides might enhance the wound-healing process by as yet
unknown mechanisms. It is well known, that proteolytic soy
protein degradation products, such as lunasin or beta-conglycinin
are bioactive. For example, lunasin reportedly inhibits inﬂamma-
tion by suppressing the NFkB signaling pathway [28] whereas
beta-conglycinins might inhibit cancer cells [29] or prevent
alopecia [30]. The fact that we see signiﬁcantly less inﬂammato-
ry/immune cell inﬂux in the SPS-treated samples (Fig. 4) than in
the granulation tissue in the untreated controls may be related to
the anti-inﬂammatory properties of lunasin or some as yet
unidentiﬁed soy-degradation products with similar anti-inﬂam-
matory properties The reported anti-alopecia properties of beta-
conglycinins may be related to our ﬁnding of enhanced regenera-
tion of skin appendages, such as hair shafts in SPS treated wounds,
but not in the untreated controls (Fig. 4). Of potential signiﬁcance
for the enhanced wound healing capabilities of SPS, some of the soy
degradation products reportedly exhibit pro-angiogenic properties
promoting neovascularization [31,32], which is an important
component of the healing process. Indeed, careful evaluation of our
micrographs shows exuberant (neo) vascularization in the vicinity
of the regenerating epithelium in SPS treated wounds (see Fig. 4).
Current studies focus on the mechanistic understanding of why
and how SPS enhances the healing process and reepithelialization
in our porcine model.
Currently we are designing several follow-up studies to (a)
evaluate the mechanisms by which soy-protein based scaffolds
enhance wound healing and (b) to directly compare SPSs with
commercially available products such as OasisTM. The latter study
will also have to address the question whether a single application
of SPSs at the time of wounding, as in this report, will sufﬁce or
whether we can enhance the efﬁcacy of soy-based scaffolds by
following multiple application protocols developed for other
bioactive wound dressings.
4. Conclusions
This works presents the potential of our soy protein scaffolds
(SPSs) to be used in the treatment of chronic wounds in humans. In
preclinical tests conducting in the porcine model, the SPSs were
shown to promote reepithelialization and a more natural, tissue-
like healing. Results of wound treatments in this model have
shown strong correlations to results obtained in humans [22]. The
use of our plant-derived scaffold circumvents current and
emerging problems with animal protein-based skin substitutes.
It also meets an unmet clinical need, as it provides affordable,
bioactive scaffolds and dressings for wound healing.
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